Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients

NCT07244419 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic Stem Cell Transplantation
Graft Failure

Interventions

DRUG: Emapalumab 3 mg/kg
DRUG: Emapalumab 10 mg/kg

Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators

[object Object]